3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Sarcoma, Kaposi
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precancerous Conditions
1
Multi-centric Castleman's Disease
1
Lymphoma, Non-Hodgkin
1
Lymphoma
1
Leukemia-Lymphoma, Adult T-Cell
1
Hodgkin Disease
1
HTLV-I Infections
1
Epstein-Barr Virus Infections
1
Castleman Disease
1
Acquired Immunodeficiency Syndrome
1
Interventions
blinatumomab
6
Cyclophosphamide
5
Rituximab
4
Tacrolimus
3
ponatinib
2
fludarabine
2
denileukin diftitox
2
Vorinostat
2
Vincristine
2
Prednisone
2
Peripheral Blood Stem Cell Transplantation
2
Methotrexate
2
Everolimus
2
Etoposide
2
Doxorubicin
2
Darbepoetin alfa
2
Cytarabine
2
Busulfan
2
Brentuximab Vedotin
2
Antilymphocyte Serum
2
Alemtuzumab
2
tetulomab tetraxetan lu-177
1
ruxolitinib
1
pembrolizumab
1
pegaspargase
1
ibrutinib
1
ibritumomab tiuxetan
1
fludarabine phosphate
1
ferrous sulfate
1
ferric gluconate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Lymphoproliferative Disorders
×
Zidovudine
×
Clear all
No trials found.